Americas Gastrointestinal Drugs Market Strategies and Competitive Analysis, Forecast Till 2023

Gastrointestinal Drugs Market , Gastrointestinal Drugs Market  Size, Gastrointestinal Drugs Market  Share, Gastrointestinal Drugs Market  Research, Gastrointestinal Drugs Market  Trends, Gastrointestinal Drugs Market  Forecast, Gastrointestinal Drugs Market  Analysis, Gastrointestinal Drugs Market  Demand, Healthcare, MarketResearchFuture.Com

Americas Gastrointestinal Drugs Market Market – Highlights

Gastrointestinal (GI) drug market involves pharmacological and non-pharmacological treatment. Different types of gastrointestinal disorder includes constipation, diverticular diseases, colon polyps, irritable bowel syndrome, and many more. Many of the GI diseases can be prevented and minimized by maintaining a healthy lifestyle and balanced diet. The factors like increasing prevalence of increasing of various different gastrointestinal disease, increasing elderly population, technological advances are responsible for driving gastrointestinal market. Whereas unavailability of treatment for some of gastro intestinal diseases may be responsible for hampering the market growth.

Try Sample Report Here @ https://www.marketresearchfuture.com/sample_request/583 .

Americas Gastrointestinal Drugs Market Market – Key Player

There are players in global and local gastrointestinal drug market: AbbVie Inc. (US), AstraZeneca (UK), Valeant (US), Abbott Laboratories(US), Allergan Plc (US), Bayer AG (Germany), Janssen Biotech Inc. (US), Takeda Pharmaceutical Company Limited (Japan), Eisai Co., Ltd. (Japan), Valeant Pharmaceuticals (US), Sanofi (France), GlaxoSmithKline Plc. (UK), Boehringer Ingelheim GmbH (Germany). Evoke Pharma (US), Valent Pharmaceuticals(US)

AstraZeneca has entered into an agreement with gastroenterology specialist Tillotts Pharma for Entocort. Entocort is a gastroenterology medicine for patients with mild to moderate Crohn’s disease and ulcerative colitis. The medicine is now available in across 40 countries, the product sales gained $53 million outside the US in 2014. The agreement shows that Tillotts will pay AstraZeneca $215 million on completion of the transaction to acquire the rights to sell and develop Entocort capsules and formulations outside the US.

Janssen Biotech Inc., the company received FDA approval for the Remicade medicine which is used to treat pediatric ulcerative colitis in 2011. Since then company has a product for pediatric gasrtrointestinal drugs.

GlaxoSmithKline Plc, has a products Eno available in Latin America and Asian market. The product is doing extremely well in these regions. The product is available in various flavor. The product is an antacid. The product is also available in different forms. Company has vast range of products in consumers based and in prescription based products. It hold very strong presence worldwide.

Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/583 .

Bayer AG, the company has a wide range of the gastrointestinal products. One of the product Iberogast is herbal product which give relief from multiple problems of gastrointestinal system.

Americas Gastrointestinal Drugs Market Market – Segmentation
The Segmentation for Americas Gastrointestinal Drug market is done on the basis of drug category, route of administration, disease type, and by end users. On the basis of the drug category the market is segmented into Acid Neutralizers, Laxatives & Antidiarrheal, Anti-inflammatory, Antiemetic and others. Further the Acid Neutralizers are sub-segmented into Antacid, H2 antagonists, Proton Pump Inhibitors and others. On the basis of route of administration the segments includes oral, parental and rectal. On the basis of disease type, market is segmented into gastro-esophageal reflux diseases, inflammatory bowel diseases and others. The inflammatory diseases are further segmented into two types Crohn’s diseases and ulcerative disease. The Ulcerative diseases are further sub segmented into ulcerative protitis, proctosigmoiditis, left sided colitis, pancolitis and acute severe ulcerartive colitis. The end user segment includes hospital pharmacies, retail pharmacies and others.

 

Americas Gastrointestinal Drugs Market Market – Regional Analysis
On regional basis America gastrointestinal drug market is segmented into two main region- North America, and South America. North America has the highest market for the gastrointestinal drug market. Increasing Geriatric Population is the major driving factor for the market of GI drugs in North America. While the major cause of the gastrointestinal diseases is stress full life and eating habit.

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/583 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: 
salesteam@marketresearchfuture.com

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Designed by CyFocus.com
Powered by CyFocus.net